A5
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for A5, covering 2012-09-20 to 2012-09-20. Get the full timeline:
Most recent: Clinical Trial Update: An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy [Phase 3]